Table 3.
Author | Recurrence location |
|||
---|---|---|---|---|
Skin/Subcutaneous | Pectoralis muscle | Deep chest wall | Total | |
Chang et al. [9] | 22 (75.9%)* | 7 (24.1%)* | 0 (0%)* | 29* |
Cont et al. [10] | 14 (200%) | 0 | 0 | 14 |
Farras et al. [11] | 8 (80%) | 2 (20%) | 0 | 10 |
Gerber et al. [12] | 4 (66.7%) | 0 | 2 (33.3%) | 6 |
Gilliland et al. [13] | 50 (80%) | 0 | 10 (20%) | 60 |
Johnson et al. [14] | 7 (100%) | 0 | 0 | 7 |
Meretoja et al. [15] | 8 (100%) | 0 | 0 | 8 |
Noone et al. [16] | 12 (75.0%) | 4 (25.0%) | 0 (0%) | 16 |
Pifer et al. [17] | 11 (64.7%) | 6 (35.3%) | 0 (0%) | 17 |
Slavin et al. [18] | 17 (100%) | 0 (0%) | 0 (0%) | 17 |
Sood et al. [19] | 6 (100%) | 0 | 0 | 6 |
Stanec et al. [20] | 15 (100%) | 0 | 0 | 15 |
Uriburu et al. [21] | 3 (100%) | 0 | 0 | 3 |
Wang et al. [22] | 96 (82.8%)** | 20 (17.2%) | 116 |
* Stratified by tumors (n = 29) across 25 patients.
** Includes both skin/subcutaneous and pectoralis muscle recurrences.